Tag archive for ‘Baraclude’
Jewish Business News On Sunday, June 15th, 2014

Teva wins US court ruling on generic breast cancer drug

– Bristol-Myers Squibb’s Baraclude has $314 million in US annual sales. –   – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that the U.S. Court of Appeals for the Federal More...

Wordpress site Developed by Fixing WordPress Problems